AlloSource Announces Raime Leeby Muhle As Chief Financial Officer

Centennial, Colo. — December 14, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced the appointment of Raime Leeby Muhle as Chief Financial Officer.

With over 18 years of experience, her background spans from emerging high growth businesses to large and mature organizations. She has worked in a variety of industries including technology, distribution, manufacturing, and telecommunications. Leeby Muhle’s expertise in complex environments, as well as working cross-functionally, will help her lead the accounting, financial, and information technology teams at AlloSource. Leeby Muhle is taking over for current Chief Financial Officer, Olivia Thompson, who is transitioning into retirement to focus on project-based work.

“We are thrilled to welcome Raime to our executive team,” said Thomas Cycyota, AlloSource President and Chief Executive Officer. “Her financial expertise and leadership, as well as her passion for our mission, will help drive AlloSource’s growth as we continue to evolve the advanced allograft therapies we provide for surgeons.”

Leeby Muhle has held various senior-level roles with finance and operational responsibilities. Prior to AlloSource, she served in key leadership positions at Arrow Electronics and Level 3 Communications.

“AlloSource has such a unique impact on our communities, and I am committed to helping the company continue to grow and innovate,” said Leeby Muhle. “I look forward to putting my background and skills towards our goal of achieving greater results in advancing biological healing.”